Acclarent

From Wikipedia, the free encyclopedia

Template:Short description

Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.

Acclarent, Inc.
Company type
Subsidiary
ISINScript error: No such module "WikidataIB".
IndustryScript error: No such module "WikidataIB".
PredecessorScript error: No such module "WikidataIB".
IncorporatedScript error: No such module "WikidataIB".
FoundedScript error: No such module "WikidataIB".
FounderScript error: No such module "WikidataIB".
DefunctScript error: No such module "WikidataIB".
SuccessorScript error: No such module "WikidataIB".
HeadquartersIrvine, California, United States
Key people
Henry J. Abdel-Hopkins (CEO)
ProductsRelieva Balloon Sinuplasty Systems
RevenueScript error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Total assetsScript error: No such module "WikidataIB".
Number of employees
Script error: No such module "WikidataIB".
ParentPage Template:Plainlist/styles.css has no content.
Websiteacclarent.com

Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".

Acclarent, Inc. began as a privately held, venture-backed company, and is now a subsidiary of Integra LifeSciences. Based in Irvine, Orange County, California.[1] it develops technology for ENT (Ear, Nose and Throat) related illnesses.

History

Founded in 2004. Acclarent has over 300 employees and operates in more than 45 countries. Acclarent’s corporate headquarters are located in the Silicon Valley in Menlo Park, California.

Since inception, the firm has reported more than $103.5M in funding from its venture partners, New Enterprise Associates (NEA), Versant Ventures, Delphi Ventures, Meritech Capital Partners, and Johnson & Johnson Development Corporation.[2]

Acclarent was founded by Joshua Makower[3] who currently serves as Acclarent’s Chairman of the Board. William M. Facteau was the company's President and Chief Operating Officer from November 2004 until March 2012. The company's president is currently Jeff Hopkins.

In May 2005, Acclarent received FDA approval[4] for its Relieva Balloon Sinuplasty technology. The company’s portfolio has more than 40 FDA-approved devices including the Relieva Balloon Sinuplasty systems, comprising the Relieva Ultirra sinus balloon catheters, the Relieva Luma sinus illumination guidewires, the Relieva Vortex which provides deep intra-sinus fluid delivery and strong shear flows to empty sinus contents, and the Cyclops articulating endoscope.[5]

In January 2010, Ethicon Inc., a Johnson & Johnson company, completed the acquisition of Acclarent.[6] In September 2017, the firm received FDA clearance for the Aera balloon, the first ever device to treat chronic eustachian tube dysfunction.

In December 2023, Integra LifeSciences announced they were acquiring Acclarent for $275m.[7] The transaction was completed on April 1, 2024.[8]

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content."Acclarent files for initial public offering". Boston Globe. 2008-06-06. Retrieved May 5, 2009.{{cite news}}: CS1 maint: deprecated archival service (link)
  2. ^ Page Module:Citation/CS1/styles.css has no content."About Us".
  3. ^ Page Module:Citation/CS1/styles.css has no content."Balloon Therapy". Forbes. 2006-05-22.
  4. ^ Page Module:Citation/CS1/styles.css has no content."ACCLARENT INC - Securities Registration Statement (S-1) SUMMARY". Archived from the original on 2021-11-08. Retrieved 2009-05-05.
  5. ^ Page Module:Citation/CS1/styles.css has no content."Balloon Sinuplasty Technology by Acclarent | Products". Archived from the original on 2009-06-01. Retrieved 2009-05-05.
  6. ^ Page Module:Citation/CS1/styles.css has no content."Ethicon Completes Acquisition of Acclarent | Ethicon". www.ethicon.com. Archived from the original on 2010-06-18.
  7. ^ Page Module:Citation/CS1/styles.css has no content."Integra LifeSciences Announces Definitive Agreement To Acquire Acclarent".
  8. ^ Page Module:Citation/CS1/styles.css has no content."Integra LifeSciences completes acquisition of Acclarent". roi-nj.com. Retrieved 2024-04-03.

Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.